Effects of Caregiver Dementia Training in Caregiver–Patient Dyads on Psychotropic Drug Prescription: A Randomized Controlled Study
Elizabeth G Birkenhäger-Gillesse,Sarah I M Janus,Wilco P Achterberg,Sytse U Zuidema,Sarah IM Janus
DOI: https://doi.org/10.2147/CIA.S314412
IF: 3.829
2021-07-27
Clinical Interventions in Aging
Abstract:Elizabeth G Birkenhäger-Gillesse, 1, 2 Sarah IM Janus, 1 Wilco P Achterberg, 3 Sytse U Zuidema 1 1 Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; 2 Laurens Care Centers, Division Long Stay, Rotterdam, the Netherlands; 3 Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands Correspondence: Elizabeth G Birkenhäger-Gillesse Laurens Care Centers, Division Long Stay, Pres. Rooseveltweg 22, Rotterdam, 3068 TR, the Netherlands Tel +31619699113 Email Purpose: Does participating in a multicomponent intervention targeting caregivers change the prescription rates of psychotropic drugs of caregivers or the person with dementia (PWD) they live with and care for. Patients and Methods: Participants were 142 dyads of community-dwelling cohabiting caregivers and PWD randomized to intervention or control (care as usual). Participating caregivers received the intervention in a holiday accommodation over five days in groups of two to six dyads. During this time, caregivers attended 14 psychoeducational group sessions on relevant emotional, relational, practical, financial, and social changes related to living with PWD. These sessions were delivered by a psychologist, a physiotherapist, an occupational therapist, an elderly care physician, a dietician and a social worker and included combating social isolation, planning for the future, re-rolling, medical aspects of dementia, fitness, therapeutic use of facilities, nutrition and using community services. The design was a randomized controlled trial. Outcomes were compared 3 months after baseline. Drug use for both caregivers and PWD were reported as all psychotropic drug use and specified as antipsychotic, antidepressant, and anxiolytic and hypnotic drug use based on Anatomical Therapeutic Chemical (ATC) classifications. Results: Compared to the control group, no significant difference was observed in psychotropic drug use by 3 months after baseline among caregivers (p 0.22 MD − 0.08 95% CI − 0.20– 0.05) or PWD (p 0.61, MD 0.04 95% − 0.12– 0.21) in the intervention group. Conclusion: A multicomponent course for caregivers living with PWD did not affect psychotropic drug use by either person. This may be explained by the low level of baseline drug use and the lack of the prescribing physician involvement in the present study. The low baseline drug use likely reflects selection bias for caregiver participants who were more inclined to use psychosocial interventions in preference to psychotropic medication, making them more likely to participate in caregiver training. Keywords: caregiver, dementia, psychotropic drugs, psychosocial intervention, training About 70% of people with dementia (PWD) live in the community. 1 Dutch demographic and prevalence data indicate that about 35% of these share a household with their primary caregiver. 2 , 3 Unfortunately, most PWD experience behavioral and psychological symptoms of dementia at some point in the course of their illness. 4 Clinical guidelines recommend nonpharmacological approaches as the first-line approach to treating these symptoms, 5 advocating that psychotropic drugs should be prescribed with restraint due to their limited effectiveness and the frequency of side effects. However, in clinical practice, psychotropic drugs are frequently prescribed to community-dwelling PWD, with percentages varying from 29% to 50% depending on the stage of dementia. 6–8 Caregivers of PWD also experience high and persistent burden that contributes to a decline in their own mental health. Therefore, psychotropic drug use is higher among these than in the general population. 9 , 10 Reported utilization rates vary by drug type, with 4–13% using antidepressants, 13–22% using anxiolytics, and 3–8% using sedatives and hypnotics. 9–11 Evidence suggests that caregiver characteristics predict psychotropic drug use, and not the severity of disease in the PWD or the perception of how well he or she is supported. 9 Interventions aimed at supporting both the PWD and the caregiver may therefore reduce neuropsychiatric symptoms in PWD and promote good mental health in their caregivers, which in turn, may reduce psychotropic drug use. We have previously published our findings on the effect of our "Mo -Abstract Truncated-
geriatrics & gerontology,gerontology